Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Combining antipsychotics; is this strategy useful?

Jill Christy1, David Burnside, Mark Agius

  • 1School of Clinical Medicine, University of Cambridge, Cambridge, UK.

Psychiatria Danubina
|November 22, 2014
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A DESCRIPTION OF ADDISON'S DISEASE, AND ITS NEUROPSYCHIATRIC MANIFESTATIONS COMPARING THE DISEASE AS IT IS NOW TO THE DISEASE AS EXPERIENCED BY SAINT ELIZABETH OF THE TRINITY IN 1906.

Psychiatria Danubina·2025
Same author

WHY IS IT IMPORTANT TO STAGE CASES OF SCHIZOPHRENIA?

Psychiatria Danubina·2025
Same author

LESSONS TO BE LEARNT FROM THE UNFORTUNATE CASE OF THE DEATH OF MOLLY RUSSELL.

Psychiatria Danubina·2025
Same author

THE DEATH OF VICTIMS AS A RESULT OF SCHIZOPHRENIA OR OTHER SERIOUS MENTAL ILLNESS; WHAT HAVE WE LEARNT OVER THE YEARS?

Psychiatria Danubina·2025
Same author

HOW SHOULD A DOCTOR REACT WHEN PERSONS EXPRESS A WISH TO SUFFER IN UNION WITH CHRIST? TRUE LOVE AND AN IMPORTANT ISSUE OF NEUROSCIENCE.

Psychiatria Danubina·2025
Same author

SAINT JOHN OF THE CROSS AND THE DEVOTION OF THE NAZZARENO OR REDENTUR; THE STORY OF HOW A SINGLE LOCUTION OR THOUGHT SPREAD ACROSS THE WORLD THROUGH EMBODIED COGNITION AND NEUROSCIENCE.

Psychiatria Danubina·2025
Same journal

Transforming women's mental health with large language models: Opportunities and challenges in digital interventions.

Psychiatria Danubina·2026
Same journal

Impact of cognitive-behavioral therapy for early postpartum depression among primiparous women.

Psychiatria Danubina·2026
Same journal

The impact of housing conditions and nutritional quality on the psycho-emotional state of young internally displaced persons during the Russo-Ukrainian war: The role of secondary stressors.

Psychiatria Danubina·2026
Same journal

Beyond the pandemic: The case for removing obsolete COVID-19 signage in clinical spaces.

Psychiatria Danubina·2026
Same journal

Revamping mariner's mental health using quantum computing techniques.

Psychiatria Danubina·2026
Same journal

Integrating Pilates and myofunctional therapy for better sleep and psychosocial outcomes in obesity-associated obstructive sleep apnea.

Psychiatria Danubina·2026
See all related articles

Combining antipsychotic drugs for schizophrenia is common but lacks strong evidence. More research is needed to confirm the efficacy and safety of these antipsychotic combinations.

Area of Science:

  • Psychiatry
  • Pharmacology

Background:

  • Antipsychotic drug combinations are frequently used in schizophrenia treatment.
  • This practice often lacks endorsement from major regulatory bodies.
  • Rationales include augmenting treatment for treatment-resistant schizophrenia (TRS) or managing side effects.

Purpose of the Study:

  • To evaluate the efficacy and safety of antipsychotic combination therapy in schizophrenia.
  • To review existing evidence from randomized controlled trials (RCTs) and case reports.

Main Methods:

  • Review of existing randomized controlled trials (RCTs) and case reports.
  • Analysis of Cochrane reviews on antipsychotic combination therapy.
  • Assessment of evidence for both efficacy and side effect management.

Related Experiment Videos

Main Results:

  • Limited RCT data exists, with Cochrane reviews unable to definitively confirm efficacy.
  • Evidence for improving side effects is inadequate; some combinations may cause adverse effects.
  • Monotherapy with adequate dosages should be prioritized before considering combinations.

Conclusions:

  • Current data is insufficient to recommend antipsychotic combinations for efficacy or safety.
  • Larger, longer-term prospective studies are essential.
  • Clinicians must ensure adequate trials of monotherapy before exploring combination strategies.